Mcl-1 is essential for the survival of plasma cells
Victor Peperzak, Ingela Vikstroem, Jennifer Walker, Stefan P Glaser, Melanie LePage, Christine M Coquery, Loren D Erickson, Kirsten Fairfax, Fabienne Mackay, Andreas Strasser, Stephen L Nutt, David M Tarlinton
Nature Immunology | NATURE PUBLISHING GROUP | Published : 2013
Awarded by Australia National Health and Medical Research Council (Independent Research Institute Infrastructure Support Scheme)
Awarded by US National Institutes of Health
We thank the facilities of our respective institutes, particularly those responsible for animal husbandry and flow cytometry; and C. Wellard, S. Chevrier, D. Segal, D. Huang, S. Heinzel, J. Marchingo, S. Willis and P. Bouillet for assistance. Supported by the Australia National Health and Medical Research Council (1043414 to I.V.; 356202 to D.M.T. and S.L.N.; 461221 to A.S.; 637326 to S.P.G.; 516786 to K.F.; and the Independent Research Institute Infrastructure Support Scheme), the Multiple Myeloma Research Foundation USA (V.P.), the European Molecular Biology Organization (V.P.), the US National Institutes of Health (AI093722 to L.D.E.) and Victorian State Government Operational Infrastructure Support.